TY - JOUR
T1 - BimABm positivity in melioidosis and its impact on clinical profile, and outcomes
T2 - a retrospective cohort study
AU - Gupta, Nitin
AU - Kumar, Tirlangi Praveen
AU - Chowdhury, Soumi
AU - Mukhopadhyay, Chiranjay
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2025/9
Y1 - 2025/9
N2 - Objectives: Melioidosis, caused by Burkholderia pseudomallei presents with diverse clinical features. Neurological involvement, though rare, is a severe complication. The BimABm allele, a variant of the Burkholderia intracellular motility A (BimA) virulence gene, has been linked to neurotropism, but data from India on this association are limited. Methods: We conducted a retrospective cohort study of 138 culture-confirmed melioidosis patients at a tertiary care center in southern India. A polymerase chain reaction assay was used to detect the BimABm allele in archived isolates. Clinical features and 28-day mortality were compared between BimABm -positive and -negative groups. Results: The BimABm allele was detected in 5.8% of isolates. Neurological involvement was significantly more common in BimABm-positive patients (50% [4/8] vs 2.3% [3/130], P < 0.001). No significant differences in comorbidities or 28-day mortality were observed between the two groups. Conclusions: Although uncommon, the BimABm allele is strongly associated with neurological melioidosis in southern India.
AB - Objectives: Melioidosis, caused by Burkholderia pseudomallei presents with diverse clinical features. Neurological involvement, though rare, is a severe complication. The BimABm allele, a variant of the Burkholderia intracellular motility A (BimA) virulence gene, has been linked to neurotropism, but data from India on this association are limited. Methods: We conducted a retrospective cohort study of 138 culture-confirmed melioidosis patients at a tertiary care center in southern India. A polymerase chain reaction assay was used to detect the BimABm allele in archived isolates. Clinical features and 28-day mortality were compared between BimABm -positive and -negative groups. Results: The BimABm allele was detected in 5.8% of isolates. Neurological involvement was significantly more common in BimABm-positive patients (50% [4/8] vs 2.3% [3/130], P < 0.001). No significant differences in comorbidities or 28-day mortality were observed between the two groups. Conclusions: Although uncommon, the BimABm allele is strongly associated with neurological melioidosis in southern India.
UR - https://www.scopus.com/pages/publications/105014966591
UR - https://www.scopus.com/pages/publications/105014966591#tab=citedBy
U2 - 10.1016/j.ijregi.2025.100723
DO - 10.1016/j.ijregi.2025.100723
M3 - Article
AN - SCOPUS:105014966591
SN - 2772-7076
VL - 16
JO - IJID Regions
JF - IJID Regions
M1 - 100723
ER -